Does USTEKINUMAB Cause Off label use? 10,990 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10,990 reports of Off label use have been filed in association with USTEKINUMAB (PYZCHIVA). This represents 12.9% of all adverse event reports for USTEKINUMAB.
10,990
Reports of Off label use with USTEKINUMAB
12.9%
of all USTEKINUMAB reports
1,395
Deaths
2,924
Hospitalizations
How Dangerous Is Off label use From USTEKINUMAB?
Of the 10,990 reports, 1,395 (12.7%) resulted in death, 2,924 (26.6%) required hospitalization, and 1,779 (16.2%) were considered life-threatening.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for USTEKINUMAB. However, 10,990 reports have been filed with the FAERS database.
What Other Side Effects Does USTEKINUMAB Cause?
Drug ineffective (12,471)
Product dose omission issue (9,405)
Fatigue (5,457)
Product use issue (5,008)
Psoriasis (4,955)
Pain (4,872)
Rash (4,736)
Crohn's disease (4,662)
Arthralgia (4,608)
Infusion related reaction (4,471)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which USTEKINUMAB Alternatives Have Lower Off label use Risk?
USTEKINUMAB vs USTEKINUMAB-STBA
USTEKINUMAB vs VADADUSTAT
USTEKINUMAB vs VALACYCLOVIR
USTEKINUMAB vs VALBENAZINE
USTEKINUMAB vs VALBENAZINE DITOSYLATE